Myeloproliferative Neoplasms

Top Story

ASH announces award recipients

July 15, 2019

St. Jude Children’s Research Hospital physician-scientist receives award

July 12, 2019
Esther Obeng, MD, PhD, received the 2019 Gertrude B. Elion Cancer Research Award from American Association for Cancer Research. The award supports early-career…
In the JournalsPerspective

Next-generation hypomethylating agent shows promise for intermediate-, high-risk myelodysplastic syndrome

July 11, 2019
Guadecitabine demonstrated clinical activity with acceptable toxicity among patients with intermediate- and high-risk myelodysplastic syndrome, according to randomized…

Dana-Farber clinic to focus on blood cancer precursor conditions

June 28, 2019
Dana-Farber Cancer Institute opened a new clinic designed to improve clinical care and monitoring for individuals with precursor conditions that can progress to blood…
More Headlines »

Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

This activity is supported by an educational grant from Merck & Co., Inc.

The treatment paradigm for the management of patients with advanced cancer has changed dramatically within recent years…
More »
Meeting News Coverage

Video: Researchers ‘eagerly await’ final data on pegylated interferon for myeloproliferative neoplasms

December 14, 2016
More »

Focus on Advancing Treatment for Acute Myeloid Leukemia

This activity is supported by an independent educational grant from Pfizer, Inc.

In this activity, Bruno Medieros, MD, and Farhad Ravandi-Kashini, MD, discuss recent advances in the treatment of acute…
More »